GI Flashcards

(59 cards)

1
Q

Harbinger of more severe disease in acute pancreatitis

A

Hemoconcentration (Hct >44%)

vs azotemia - significant risk factor for mortality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Risk factors for severity in acute pancreatitis

A

Agre >60
BMI >30
Comorbid disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Most important clinical finding regarding severity of the acute pancreatitis episode

A

Persistent organ failure (>48h)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

IV fluid resuscitation in Acute pancreatitis

A

PLR or normal saline initially bolused at 15-20mL/kg (1050-1400mL) followed by 2-3mL/kg/hr (200-250mL/h) to maintian UO >0.5mL/kg/hr

*Repeat volume challange with 2L crystalloid bolus and increase rate to 1.5mg/kg/hr if (+) rise in Hct or BUN during serial measurement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Components of BISAP score

A

BUN >25
Impaired mental status (GCS<15)
SIRS
Age > 60
Pleural effusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

2 most common etiologic factors for recurrent acute pancreatitis

A

Alcohol and cholelithiasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Treatment of steatorrhea in chronic panccreatitis

A

Enzyme therapy
Lipase 25,000-50,000 units during each male (up to 100,000 units depending on response, nutritional parameters, and /or panreas function results)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

2 types of gallstones

A

Cholesterol and pigment stones

Cholsteerol - more common in West (90%)
Pigment - brown/black (*brown forms secondary to chronic liary infection)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Most important mechanism in the formation of lithogenic bile

A

Increased biliary secretion of cholesterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Conditions that are associated with cholesterol-stone or biliary sludge formation

A

Pregnancy and rapid weight reduction through very low calorie diet

*UDCA 600mg/day proved highly effective in preventing gallstone formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

3 factors to consider to recommend cholecystectomy

A

(1) the presence of symptoms that are frequent enough or severe enough to interfere with the patient’s general routine;

(2) the presence of a prior complication of gallstone disease, that is, history of acute cholecystitis, pancreatitis, gallstone fistula, etc.; or

(3) the presence of an underlying condition predisposing the patient to increased risk of gallstone complications (e.g., a previous attack of acute cholecystitis regardless of current symptomatic status)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Patient profile who will benefit frmo UDCA

A

Radiolucent <5mm in diameter (stones >10mm rarely dissolve)
Functioning galbladder
CHOLESTEROL STONES ONLY (pigment not responsive

Give UDCA 10-15mg/kg/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Bacteria most frequently cultures in emphysematous cholecystitis

A

Anarobes, C. welchii or C. perfringes
and aerobes - E coli

*most frequent in DM px and men
*Prompt surgical intervention & antibiotics needed
*diagnosed on plain abdominal film (+) gas within the gallbladder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Jaundice without dark urine is typical of…

A

Hemolytic anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Toxin that causes watery diarrhea by acting directly on secretory mechanisms in intestinal mucosa

A

Enterotoxin .. watery diarrhea

*Cholera-increases cAMP to increase Cl secretion and decrease Na absorption
*Enterotoxigenic strains of E. coli (heat labile, similar to cholera
and heat stable guanlyate cyclase and elevation of cGMP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Toxin that causes destruction of mucosal cells and associated inflammatory diarrhea

A

Cytotoxins .. produce dysentery

*Shigella dystenteriae type 1
*Vibrio parahaemolyticus
*C. difficile

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Toxin that act directly on CNS or PNS to cause diarrhea

A

Neurotoxins … causes symptoms SOON after ingestion

*Staphylococcal
*Bacillus cereus toxins - CNS –> vomiting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Bacterial food poisoning: Agents that have 8-16h incubation period

A

Clostridium perfringens (beef, poultry, legumes, gravies)

B. cereus diarrheal form (meats vegetables, dried beans, cereals)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Antibacterial drugs for dysentery

A

If the level of suspicion is low for fluoroquinolone-resistant Campylobacter: Adults:
(1) A fluoroquinolone such as ciprofloxacin, 750 mg as a single dose or 500 mg bid for 3 days; levofloxacin, 500 mg as a single dose or 500 mg qd for 3 days; or norfloxacin, 800 mg as a single dose or 400 mg bid for 3 days

(2) Azithromycin, 1000 mg as a single dose or 500 mg qd for 3 days

(3) Rifaximin, 200 mg tid or 400 mg bid for 3 days (not recommended for use in dysentery).

*If with travel to Southeast asia, Azithromycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Type of ascites presenting with SAAG >1.1 g/dL

A

Cirrhosis
Late Budd-Chiara syndrome
Massive liver metastases
————
Heart failure/constrictive pericarditis
Early Budd-Chiari syndrome
IVC obstruction
Sinusoidal obstruction syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Type of ascites presenting with SAAG < 1.1 g/dL (5)

A

Biliary leak
Nephrotic syndrome
Pancreatitis
Peritoneal carcinomatosis
Tuberculosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

SAAG >1.1g/dL, ascitic protein > 2.5

A

Heart failure/constrictive pericarditis
Early Budd-Chiari syndrome
IVC obstruction
Sinusoidal obstruction syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

SAAG >1.1g/dL, ascitic protein < 2.5

A

Cirrhosis, Late Budd-Chiari syndrome,
Massive liver mets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Diagnostic criteria for IBS

A

Rome IV: recurrent abdominal pain at least once a week for 3 months, associated with 2 or more:
Related to defacation
Associated with change in frequency of stool
Associated with change in form/appearance of stool

25
Definition of portal hypertension (in mmHg)
Elevation of hepatic venous gradient to >5mmHg *Clinically significant portal hypertension is >10mmHg
26
Most common cause of portal hypertension
Cirrhosis
27
3 primary complications of portal hypertension
Gastroesophageal varices with hemorrhage Ascites Hypersplenism
28
Usually the first indication of portal hypertension
Congestive splenomegaly and hypersplenismDI
29
Diuretics used in ascites management
Spironolactone 100mg/day single dose up to max 400mg/day Furosemide 40mg/day then up to 160mg/day
30
Management of hepatorenal syndrome
Diuretics should be stopped Infusion of albumin 1g/kg is recommended Tx with vasoconstrictors (terlipressin, low dose NE, midodrine) Best therapy: liver transplant
31
Duration of refractory GU
Failure to heal after 12 weeks
32
Duration of refractory DU
Failure to heal after 8 weeks
33
Major types of chemical hepatotoxicity
Direct toxic & idiosyncratic
34
Characteristics of idiosyncratic drug reaction
Liver injury is infrequent Response not as clearly dose dependent,unpredictable May occur anytime after exposure (Typically 5-90 days following initiation)
35
Four agents that have phenotype of autoimmune hepatitis, with high likelyhood of positive ANA
Nitrofurantoin Minocycline Hydralazine Methyldopa
36
R value (ratio of ALT to alkaline phosphatase values) cut offs to determine hepatocellular or cholestatic injury
R>5 Hepatocellular 2-5 Mixed <2 Cholestatic
37
Prototype drugs that cause idiosyncratic drug reaction
Co-amoxiclav Isoniazid Ciprofloxacin *Direct toxic: Acetaminophen, carbon tetrachloride
38
Most common agent implicated as causing DILI in US and EU
Co-amoxiclav
39
Type of reaction caused by Amiodarone hepatotoxicity
Toxic AND idiosyncratic *Can present with modest serum aminotransferase elevations, detectable hepatomegaly
40
Type of reaction caused by Statin hepatotoxicity
Idiosyncratic mixed hepatocellular and cholestatic reaction
41
Signs to suspect CBD stone in px with cholecystitis
Serum bili >5mg/dL (if >15, suspect concomitant hepatic or renal disease or other actor lreading to marked hyperbilirubinemia) Elevated ALP (often precedes clinical jaundice) 2-10 fold elevation of ALT
42
Preferred initial procedure for cholangitis
ERCP with sphincterotomy
43
4 serologic tests to request for px with acute hepatitis
HbsAg Anti HBc IgM Anti HAV IgM Anti HCV
44
Initial testing in chronic hepatitis
HbsAg and anti HCV If established Hep B, test for HbeAg and anti-Hbe to evaluate relative infectivity
45
Sine qua non for determining on treatment and durable responsiveness when treating for hepatitis C
HCV RNA *Not a reliable marker of disease severity or prognosis but helpful in predicting relative RESPONSIVENESS to antiviral therapy
46
Features suggesting progression of acute to chronic hepatitis
1) lack of complete resolution of symptoms, persistence of hepatomegaly 2) presence of bridging/interface or multilobular hepatic necrosis on liver biopsy during protracted, severe acute viral hepatitis 3)failure of serum aminotransferase, bilirubin, and globulin levels return to normal within 6-12 months after acute illness 4) persistence of HbeAg > 3 months or HbsAg > 6 months
47
Tx duration for acute viral hepatitis
should continue until 3 months after HBsAg seroconversion or 6 months after HBeAg seroconversion
48
Adjuncts in mgt of acute viral hepatitis
Severe pruritus - cholestyramine Glucocorticoids - no value Blood precautions for hep B and C
49
Conventional serum marker for HBV replication
HbeAg
50
Most important risk factor for the ultimate development of cirrhosis and HCC
Level of HBV replication
51
Antiviral recommended for chronic hep B with reduced renal function (CrCl <50)
Tenofovir alafenamide (TAF)
52
Treatment pearls in chronic Hep B
Treat only if HBV DNA >2x10^3 IU/mL and ALT >ULN (*except in compensated cirrhosis - treat as long as HBV DNA is detectable at >2x10^3, if decompensated-treat) PEG IFN not used for immunocompromised or IFN-intolerant/refffractory Oral agents are administered daily for at least a year and 6 months after HbeAg seroconversion
53
2 major histologic features suggesting chronicity of UC
-Crypt architecture of the colon is distorted -Basal plasma cells and multiple basal lymphoid aggregates
54
IBD complications more common in UC
Pyoderma gangrenosum Primary sclerosing cholangitis *More common in CD- peripheral arthritis, erythema nodosum, AS, nephrolithiasis, reactive amyloidosis *Equal = sacroiliitis
55
Extraintestinal manifestations of IBD that correlate with bowel activity
Erythema nodosum Peripheral arthritis - worsens with exacerbation *Does not correlate: Psoriasis, ankylosing spondylitis, sacroiilitis
56
UC patients who are more likely to require biologics
Moderate to severe disease Steroid dependent Steroid refractory (+) Refractory pouchitis
57
CD patients who are more likely to require biologics
<30 years old, extensive disease Perianal or severe rectal disease and/or deep ulcerations in the colon Structuring and penetrating disease behavior
58
Most common cause of acute gastritis
Infectious
59
2 types of chronic gastritis
Type A: body predominant (autoimmune), associated with pernicious anemia, gastrin levels markedly elevated >500pg/mL Type B: antral predominant, H. pylori related more common Histology improves after H pylori eradication